In gynecology, Plasmolifting™ technology is used to treat reproductive system diseases by injection of patient's blood plasma obtained with our technology into the treated areas.
The therapeutic benefit of Plasmolifting™ procedure is determined by plasma-derived growth factors that stimulate repair of various tissues, including mucous membranes.
As part of combination therapy for inflammatory diseases of the female reproductive system, vulvar dystrophy (kraurosis vulvae, leukoplakia), chronic endometritis, recurrent endogenous and exogenous infections of the cervix, Plasmolifting™ technology provides a sustained therapeutic effect and helps reduce total treatment time. Our approach promotes healing of the tissues affected by an inflammatory process and improves the patients’ quality of life.
When indicated, it is a good practice to combine Plasmolifting™ procedure with the Plasmolifting™ Gel therapy.